Clarivate PLC (CLVT)

Several events have impacted Clarivate Plc's stock price in the past six months. The Q4 2025 earnings report showed a decrease in full-year revenue but a narrowed net loss and increased free cash flow, with discussions to sell the Life Sciences & Healthcare business. The Q1 2026 earnings report beat analyst estimates, leading to a surge in shares, debt retirement, and reaffirmed full-year guidance. Product launches included Clarivate Nexus, Nexus Connect, and Web of Science Research Intelligence. The strategic review of the Life Sciences & Healthcare business has been a significant point of investor attention. Clarivate has been actively focusing on simplifying its capital structure, reducing debt, and improving financial flexibility. Analyst sentiment has been cautious, with some downgrades due to concerns about AI disruption risks and uncertainty surrounding the planned LS&H unit sale.

Clarivate Plc's business model is characterized by a high degree of stability and predictability in demand due to its subscription-based model, with over 80% of total revenue derived from subscriptions and other recurring sources. High customer retention rates make the company less vulnerable to economic cycles and suggest minimal seasonality in demand. Customers integrate Clarivate's platforms into their processes, leading to high switching costs and consistent demand, indicating a stable demand profile throughout the year.

Clarivate Plc is a British-American publicly traded analytics company providing transformative intelligence to customers in academia, government, law, life sciences, and healthcare. Its business model centers on subscription-based services and software workflow solutions. The company's major products and services are categorized into Academia & Government (A&G), Intellectual Property (IP), and Life Sciences & Healthcare (LS&H). The A&G segment offers research and analytics, content aggregation, and workflow software solutions. The IP segment provides IP Maintenance, IP Intelligence, and IP Management solutions. The LS&H segment delivers research and development, regulatory and safety, and commercialization solutions. The company also offers consulting services and has been investing in AI-enabled solutions.

Clarivate Plc has a multinational footprint with headquarters in London, UK, and Philadelphia, USA. Approximately half of the company's revenue is generated in the Americas, with Europe, the Middle East, and Africa accounting for about a quarter. Clarivate also has a significant presence in Asia, including China, India, Japan, Korea, Singapore, Malaysia, Indonesia, and Thailand. The company has established global business centers in Penang, Malaysia; Chandler, Arizona, USA; and London, UK. Clarivate employs over 10,000 staff in more than 40 countries worldwide.

Clarivate has cultivated a trusted reputation as a global leader through its continued investment in content, workflows, and an AI-first mindset. New solutions such as Innography AI Classifier, SEP Analyzer, Web of Science Research Intelligence, and Nexus Connect contribute positively to its brand image as an innovator. Strategic partnerships and collaborations with organizations like Sinopec, the University of Melbourne, and FECYT further enhance its reputation. However, the company faces ongoing legal challenges related to securities claims and intellectual property disputes, which could potentially impact its financial performance and reputation.

Clarivate Plc has significant institutional ownership, with 224 institutional owners and shareholders holding a total of 564,362,834 shares as of April 25, 2026. Institutional investors collectively held 80.7% of Clarivate's outstanding shares as of December 2025. Major institutional owners include Leonard Green & Partners, L.P., Exor N.V., and Clarkston Capital Partners, LLC. Major individual owners include Usama Cortas, Michael J. Angelakis, and Andrew Miles Snyder.